Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04588363 · ClinicalTrials.gov registry record
COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 244
- Enrollment target
NCT04588363 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 244 participants.
The verdict
NCT04588363 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 244 participants
- Enrollment target
Study Summary
The primary objectives of this study are: * To determine the proportion of children with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) related death, rehospitalization or major complications after infection with SARS-CoV-2 and/or Multisystem Inflammatory Syndrome in Children (MIS-C), and * To determine immunologic mechanisms and immune signatures associated with disease spectrum and subsequent clinical course during the year of follow-up.
Interventions
- OTHER SARS-CoV-2 and/or MIS-C Exposure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 244 participants |
| Start Date | 2020-11-19 |
| Est. Completion | 2023-03-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04588363
The ClinicalTrials.gov registry entry for NCT04588363 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 244 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SARS-CoV-2 and/or MIS-C Exposure is the first listed.
NCT04588363 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04588363 about?
NCT04588363 is a clinical study titled "COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C". The primary objectives of this study are: * To determine the proportion of children with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) related death, rehospitalization or major complications after infection with SARS-CoV-2 and/or Multisystem Inflammatory Syndrome in Children (MIS-C),...
What is the current status of trial NCT04588363?
This trial is currently completed. The enrollment target is 244 participants. The study started on 2020-11-19. Estimated completion is 2023-03-03.
What interventions are being tested in trial NCT04588363?
The interventions under investigation include: SARS-CoV-2 and/or MIS-C Exposure (OTHER).
Who is sponsoring clinical trial NCT04588363?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.